MICHAEL MORNEAU Insider Trading $VKTX Viking Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL MORNEAU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL MORNEAU. MICHAEL MORNEAU is VP Finance & CAO in Trius Therapeutics Inc ($TSRX) and VPF and CAO in Trius Therapeutics Inc ($TSRX) and Chief Financial Officer in Viking Therapeutics, Inc. ($VKTX) and VP, Finance and Administration in Viking Therapeutics, Inc. ($VKTX).
MICHAEL MORNEAU in Viking Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL MORNEAU: VP, Finance and Administration, Chief Financial Officer
Holdings: 116,062 shares
Current Value: $168,290
Latest Transaction: Jan 19 2021
$VKTX Market Capitalization: $31.36M
$VKTX Previous Close: $1.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL MORNEAU in Viking Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Payment of Exercise | F | 6.68 | 1,685 | 11,256 | 116,062 | 117.7 K to 116.1 K (-1.43 %) |
| Jan 06 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Option Exercise | A | 5.80 | 33,000 | 191,400 | 33,000 | |
| Jan 06 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Payment of Exercise | F | 5.80 | 2,739 | 15,886 | 117,747 | 120.5 K to 117.7 K (-2.27 %) |
| Jan 06 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Grant | A | 0.00 | 6,667 | 0 | 120,486 | 113.8 K to 120.5 K (+5.86 %) |
| Jan 06 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Grant | A | 0.00 | 14,667 | 0 | 113,819 | 99.2 K to 113.8 K (+14.79 %) |
| Sep 16 2020 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Payment of Exercise | F | 6.25 | 1,557 | 9,731 | 97,873 | 99.4 K to 97.9 K (-1.57 %) |
| Sep 16 2020 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Grant | A | 0.00 | 4,500 | 0 | 99,430 | 94.9 K to 99.4 K (+4.74 %) |
| Apr 03 2020 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Option Exercise | A | 4.68 | 15,000 | 70,200 | 15,000 | |
| Jan 21 2020 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Payment of Exercise | F | 7.18 | 2,044 | 14,676 | 92,840 | 94.9 K to 92.8 K (-2.15 %) |
| Jan 03 2020 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Option Exercise | A | 7.77 | 40,000 | 310,800 | 40,000 | |
| Oct 31 2019 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Option Exercise | A | 6.47 | 2,500 | 16,175 | 2,500 | |
| Aug 02 2019 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Option Exercise | A | 7.69 | 7,500 | 57,675 | 7,500 | |
| Jan 22 2019 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Payment of Exercise | F | 8.78 | 2,044 | 17,946 | 91,991 | 94 K to 92 K (-2.17 %) |
| Jan 03 2019 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Option Exercise | A | 7.58 | 29,000 | 219,820 | 29,000 | |
| May 31 2018 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Sell | S | 9.25 | 21,551 | 199,347 | 94,035 | 115.6 K to 94 K (-18.64 %) |
| May 08 2018 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Payment of Exercise | F | 4.22 | 7,616 | 32,140 | 94,035 | 101.7 K to 94 K (-7.49 %) |
| Jan 23 2018 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | Chief Financial Off ... | Option Exercise | A | 4.65 | 52,500 | 244,125 | 52,500 | |
| Jan 23 2018 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 101,651 | 86.7 K to 101.7 K (+17.31 %) |
| May 05 2017 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | Chief Financial Off ... | Payment of Exercise | F | 1.34 | 8,192 | 10,977 | 80,604 | 88.8 K to 80.6 K (-9.23 %) |
| Jan 05 2017 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | Chief Financial Off ... | Option Exercise | A | 1.23 | 17,605 | 21,654 | 17,605 | |
| Jan 05 2017 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | Chief Financial Off ... | Option Exercise | A | 1.23 | 95,000 | 116,850 | 95,000 | |
| Mar 15 2016 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | Chief Financial Off ... | Option Exercise | A | 1.88 | 19,934 | 37,476 | 19,934 | |
| Mar 08 2016 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | Chief Financial Off ... | Option Exercise | A | 2.15 | 40,000 | 86,000 | 40,000 | |
| May 06 2015 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | Chief Financial Off ... | Option Exercise | A | 9.49 | 25,500 | 241,995 | 25,500 | |
| May 06 2015 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | Chief Financial Off ... | Payment of Exercise | F | 9.49 | 10,404 | 98,734 | 77,404 | 67 K to 77.4 K (+15.53 %) |
| May 06 2015 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | Chief Financial Off ... | Grant | A | 0.00 | 67,000 | 0 | 67,000 | 0 to 67 K |
Page: 1